An Observational Study of Anxiety and Depression in Idiopathic Pulmonary Fibrosis

Aims: Anxiety and depression are common in idiopathic pulmonary fibrosis (IPF). The longitudinal relationships between mental health and disease severity, progression and symptom burden are unknown. This study aims to identify if the prevalence and severity of anxiety and depression in IPF is associated with disease severity and progression. Also, to observe whether changes in cough and breathlessness symptom severity are associated with changes in mental health. Study Design: Retrospective case note review. Place and Duration of Study: Department of Respiratory Medicine, University Hospital Llandough, Cardiff between November 2010 and August 2012. Methodology: Data was collected from 37 patients with IPF from two out-patient visits 12 months apart. Data included patient demographics, lung function measurements (FVC/TLco), hospital anxiety and depression scores, Denver ILD breathlessness score and Leicester cough questionnaire. Results: The proportion of patients with depressive symptoms increased from 24.3% at baseline to 43.6% at 12 months. Anxiety rates fell from 40.5% at baseline to 35.1%. 12 patients (32%) had severe pulmonary fibrosis and 14 patients (38%) had progressive fibrosis. Patients with severe or progressive disease were more likely to have a clinically important increase in anxiety (severe P = .02, progressive P = .008) and depression scores (severe P = .008, progressive P = .04) compared with those with mild or stable Original Research Article Pink et al.; AIR, Article no. AIR.2014.6.002 321 disease. An association was identified between worsening depression and increasing dyspnoea (r = .60, P = .01) and cough related quality of life (r = -.47, P = .01). Increasing anxiety was also associated with dyspnoea (r = .38, P = .05) and cough (r = -.39, P = .05). Conclusion: Anxiety and depression are highly prevalent in IPF and are associated with severe and progressive disease. Increasing symptom burden is associated with worsening mental health.

[1]  M. Gould,et al.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review , 2005, Thorax.

[2]  Y. Kondoh,et al.  Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis , 2008, Respirology.

[3]  P. Bailey.  The Dyspnea-Anxiety-Dyspnea Cycle—COPD Patients’ Stories of Breathlessness: “It’s Scary /When you Can’t Breathe” , 2004, Qualitative health research.

[4]  R. Tachikawa,et al.  Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease , 2012, Respirology.

[5]  H. Collard,et al.  Depression and functional status are strongly associated with dyspnea in interstitial lung disease. , 2011, Chest.

[6]  Yanan Zhu,et al.  Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study , 2012, BMC Pulmonary Medicine.

[7]  J. Vries,et al.  Quality of life of idiopathic pulmonary fibrosis patients. , 2001, The European respiratory journal.

[8]  N. Siafakas,et al.  Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. , 2011, Primary care respiratory journal : journal of the General Practice Airways Group.

[9]  A. A. Raj,et al.  Clinical cough IV:what is the minimal important difference for the Leicester Cough Questionnaire? , 2009, Handbook of experimental pharmacology.

[10]  R. Hubbard,et al.  The rising incidence of idiopathic pulmonary fibrosis in the UK , 2011, Thorax.

[11]  H. Meltzer,et al.  Psychiatric morbidity among adults living in private households, 2000 , 2003, International review of psychiatry.

[12]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[13]  A. Morice,et al.  Chronic persistent cough in the community: a questionnaire survey , 2007, Cough.

[14]  N. Siafakas,et al.  Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. , 2005, European journal of internal medicine.

[15]  Nicola A Hanania,et al.  Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs. , 2008, Chest.

[16]  R. Snaith,et al.  The Hospital Anxiety and Depression Scale , 1983 .

[17]  Sally J. Singh,et al.  Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ) , 2003, Thorax.

[18]  H. Schünemann,et al.  The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease , 2008, Health and quality of life outcomes.

[19]  M. Tsukino,et al.  Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study , 2012, Respiratory Research.

[20]  A. Wells,et al.  Interstitial lung disease guideline , 2008, Thorax.

[21]  Y. Lacasse,et al.  Anxiety and depression in end-stage COPD , 2008, European Respiratory Journal.

[22]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[23]  M. Schwarz,et al.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. , 1986, The American review of respiratory disease.

[24]  J. K. van den Berg,et al.  Reliability and validity of a Dutch version of the Leicester Cough Questionnaire , 2007, Cough.

[25]  H. Collard,et al.  Depression is a common and chronic comorbidity in patients with interstitial lung disease , 2012, Respirology.